Evaxion Biotech AS (EVAX) stock has reached a new 52-week low, touching down at $3.06, with InvestingPro data showing the stock's RSI indicating oversold territory. The company faces a challenging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback